Ionis Pharmaceuticals Exec Says Zanvastro Will Be Available At List Price Of $285K Per Dose
https://ir.ionis.com/events/event-details/zanvastrotm-zilganersen-fda-approval-webcas
Ionis announced their new medicine Zanvastro will cost $285,000 per dose. When a medicine costs this much, watch how many patients can actually get it and whether insurance companies will help pay—that tells you if the company can really make money from it.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.